Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-13 Sale |
2020-11-17 6:50 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $20 | $15,000 | 362,114 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-17 6:49 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $20 | $140,000 | 355,293 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 4:20 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $21.73 | $16,298 | 362,864 (Direct) |
View |
| 2020-09-15 Sale |
2020-09-17 4:18 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $21.77 | $152,389 | 362,293 (Direct) |
View |
| 2020-08-31 Sale |
2020-09-02 4:47 pm |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
26,700 | $20.05 | $535,282 | 425,865 (Direct) |
View |
| 2020-08-31 Sale |
2020-09-02 4:42 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
11,307 | $20 | $226,197 | 369,293 (Direct) |
View |
| 2020-08-28 Sale |
2020-09-01 4:37 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $20.02 | $496,421 | 584,908 (Direct) |
View |
| 2020-08-27 Sale |
2020-08-31 5:02 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
9,147 | $19.07 | $174,454 | 446,463 (Direct) |
View |
| 2020-08-26 Sale |
2020-08-28 5:41 pm |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
2,700 | $20.02 | $54,052 | 761,865 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 5:07 pm |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $20 | $14,000 | 388,414 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 5:04 pm |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
600 | $20 | $12,000 | 455,265 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 5:02 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
635 | $20 | $12,700 | 389,480 (Direct) |
View |
| 2020-06-24 Sale |
2020-06-26 4:23 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
17,446 | $20 | $348,920 | 470,665 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-24 4:16 pm |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
4,054 | $20 | $81,080 | 401,061 (Direct) |
View |
| 2020-05-19 Purchase |
2020-05-21 1:25 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
87,897 | $12.31 | $1,081,912 | 48,641,181 (Indirect) |
View |
| 2020-05-15 Purchase |
2020-05-19 3:13 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
84,812 | $12.22 | $1,036,590 | 48,553,284 (Indirect) |
View |
| 2020-05-13 Purchase |
2020-05-15 3:28 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
91,331 | $12.18 | $1,112,401 | 48,468,472 (Indirect) |
View |
| 2020-05-11 Purchase |
2020-05-13 6:50 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
59,448 | $13.08 | $777,789 | 48,377,141 (Indirect) |
View |
| 2020-05-06 Purchase(A) |
2020-05-11 4:07 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
50,000 | $12.24 | $612,075 | 48,247,693 (Indirect) |
View |
| 2020-05-07 Purchase |
2020-05-11 4:01 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
70,000 | $12.73 | $891,212 | 48,317,693 (Indirect) |
View |
| 2020-05-05 Purchase |
2020-05-07 09:26 am |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
100,000 | $11.97 | $1,196,540 | 48,247,693 (Indirect) |
View |
| 2020-05-01 Purchase |
2020-05-05 3:40 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
100,000 | $11.44 | $1,144,050 | 48,147,693 (Indirect) |
View |
| 2020-04-29 Purchase |
2020-05-01 5:35 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
100,000 | $12 | $1,199,720 | 48,047,693 (Indirect) |
View |
| 2020-04-27 Purchase |
2020-04-29 1:38 pm |
Myovant Sciences Ltd. | MYOV | Sumitomo Chemical Co. Ltd. Dainippon Sumitomo Pharma Co Ltd Sumitovant Biopharma Ltd. 10% Owner |
90,503 | $12.11 | $1,096,022 | 47,947,693 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-13 Exercise |
2020-11-17 6:50 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 362,114 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-17 6:50 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 362,114 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-17 6:49 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $0 | 355,293 (Direct) |
View |
| 2020-11-13 Exercise |
2020-11-17 6:49 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $7.78 | 355,293 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:20 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $0 | 362,864 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:20 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
750 | $5.11 | 362,864 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:18 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $0 | 362,293 (Direct) |
View |
| 2020-09-15 Exercise |
2020-09-17 4:18 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
7,000 | $7.78 | 362,293 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:16 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | Curran Terrie Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:15 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | GUINAN MARK Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:14 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | Gulfo Adele M. Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:13 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | POTTER MYRTLE S Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-09-15 Option Award |
2020-09-17 4:12 pm |
N/A 2030-09-14 |
Myovant Sciences Ltd. | MYOV | Sebelius Kathleen Director |
21,603 | $0 | 21,603 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-02 4:47 pm |
N/A 2027-07-16 |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
26,700 | $0 | 425,865 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-02 4:47 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
26,700 | $7.78 | 425,865 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-02 4:42 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
11,307 | $0 | 369,293 (Direct) |
View |
| 2020-08-31 Exercise |
2020-09-02 4:42 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
11,307 | $7.78 | 369,293 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:37 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $0 | 584,908 (Direct) |
View |
| 2020-08-28 Exercise |
2020-09-01 4:37 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
24,800 | $5.11 | 584,908 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 5:02 pm |
N/A 2029-04-04 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
2,058 | $0 | 446,463 (Direct) |
View |
| 2020-08-28 Exercise |
2020-08-31 5:02 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
2,058 | $7.78 | 446,463 (Direct) |
View |
| 2020-08-26 Exercise |
2020-08-28 5:41 pm |
N/A 2027-07-16 |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
2,700 | $0 | 761,865 (Direct) |
View |
| 2020-08-26 Exercise |
2020-08-28 5:41 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
2,700 | $7.78 | 761,865 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:07 pm |
N/A 2026-09-20 |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $0 | 388,414 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:07 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | KARBE FRANK Principal Fin'l & Accounting |
700 | $5.11 | 388,414 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:04 pm |
N/A 2027-07-16 |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
600 | $0 | 455,265 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:04 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Lang Matthew General Counsel & Corp. Secy. |
600 | $7.78 | 455,265 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:02 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
635 | $0 | 389,480 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 5:02 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
635 | $7.78 | 389,480 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:23 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
17,446 | $0 | 470,665 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:23 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
17,446 | $7.78 | 470,665 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 4:16 pm |
N/A 2027-08-14 |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
4,054 | $0 | 401,061 (Direct) |
View |
| 2020-06-23 Exercise |
2020-06-24 4:16 pm |
N/A N/A |
Myovant Sciences Ltd. | MYOV | Arjona Ferreira Juan Camilo Chief Medical Officer |
4,054 | $7.78 | 401,061 (Direct) |
View |